COVID-19 severity not linked to long-term problems
Fatigue, ill-health and breathlessness are all common following COVID-19.
Fatigue, ill-health and breathlessness are all common following COVID-19.
Most people hospitalised with COVID-19 have at least one symptom six months after falling ill, according to a follow-up study of people in Wuhan China.
The European Medicines Agency gave its backing to 15 new medicines at its December meeting, taking its total for the year to 96.
The European Medicines Agency (EMA) has confirmed that health authorities can extract six doses of vaccine from each vial of Comirnaty, a vaccine against COVID-19 manufactured by Pfizer/BioNTech.
Cybercriminals hacked into the European Medicine Agency (EMA) in December to steal key files related to COVID-19 vaccines, the agency has confirmed.
We live in a world invaded by plastic. Its role as a chemically stable, versatile and multi-purpose fostered its massive use, which has finally translated into our current… read more.
Interview and article by Christine Clark A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) used distance matrices to match RA cases… read more.
Interview and article by Chrstine Clark The findings of a recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) could have important implications… read more.
Interview and article by Christine Clark A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) produced a number of interesting findings, Dr… read more.
Interview and article by Christine Clark. Rheumatoid arthritis (RA) affects about one percent of the population in the UK and comorbidities are reported to be common. A recent… read more.
Attention Deficit Hyperactive Disorder (ADHD) can have negative consequences on mental health into adulthood.
Article written by Bruce Sylvester Among persons with prediabetes, a lifestyle intervention can almost halve the risk of developing Type 2 diabetes, researchers from a large, new study… read more.